A comparative study of the efficacy and safety of olopatadine 0.7% versusalcaftadine 0.25% in allergic conjunctivitis - NI

Pt B.D. Sharma UHS Rohtak0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•Positive medical history of mild to moderate ocular allergies.
•-Best corrected visual acuity of 6 by 12 or better in each eye.
•-Absence of contact lens use for a minimum of three days before and throughout the study period.
•-Willingness to provide informed consent

•-Diagnosis of persistent dry eye syndrome.
•-Use of any topical eye drops, including ocular lubricants, aside from the investigational drugs within the past seventy two hours, or utilization of any experimental medications or devices within the last thirty days.
•-Taking aspirin, or related products, systemic steroids or H1antihistamines within seven days prior to enrolment.
•-Presence of an active ocular infection.
•-Planned surgical procedures during the study period or recent ocular surgical intervention within three months.
•-Pregnancy and lactation

发起方

Pt B.D. Sharma UHS Rohtak